How do Real World Data (RWD) and Real World Evidence (RWE) professionals see their critical role developing?
- Which teams are using RWD/RWE, where is it providing most value and how might this change over the next 2 years?
- What are the main challenges faced by RWD/RWE professionals?
- How is the collection of RWD/RWE planned and what factors drive these decisions?
- When in a product’s lifecycle should RWD/RWE collection start and how might this change?
RWD and RWE play an increasingly important role in proving the value and utility of drugs. The insights provided go beyond clinical research results and regulatory approval to deliver persuasive real world evidence to key stakeholders such as payers. Yet RWD/RWE professionals face a number of challenges and the discipline is having to adapt to ever increasing workloads and developing market demands.